Youth and non-European ethnicity are associated with increased loss of publicly funded insulin pump access in New Zealand people with type 1 diabetes
- PMID: 33131079
- DOI: 10.1111/dme.14450
Youth and non-European ethnicity are associated with increased loss of publicly funded insulin pump access in New Zealand people with type 1 diabetes
Abstract
Aims: Continuous subcutaneous insulin infusion (CSII) has been publicly funded in New Zealand for people living with type 1 diabetes since 2012. The aim of the current study was to investigate the loss of access, once obtained, to public-funded CSII. The frequency and socio-demographics of access, and loss, to CSII spanning the period 2012 to 2018 were examined.
Methods: Nationally held data collections including the New Zealand Virtual Diabetes Register were used to calculate the overall and subgroup proportions using and ceasing CSII. A logistic regression model was used to estimate odds ratios for pump use for the predictor variables (sex, age group, ethnicity and deprivation index) and to calculate odds ratios for pump cessation for the same demographic factors.
Results: Once CSII access is obtained, approximately 4% per year cease CSII in a subsequent year. This cessation of publicly funded CSII was not distributed equally among the population, showing over-representation in youth (aged 10-29 years) and non-Europeans, in particular Māori and Pasifika. Compounding this, it remains less likely for people with diabetes to initially access publicly funded CSII in New Zealand if they are non-European and more socio-economically deprived.
Conclusions: In New Zealand, Māori and Pasifika, as well as youth, are over-represented in the cessation of CSII in comparison with Europeans and all other age groups. These groups are also less likely to gain initial access to public funding. Efforts to understand and reduce these disparities are needed, including review of current public funding access criteria.
Keywords: continuous subcutaneous insulin infusion; diabetes; equity; insulin pump.
© 2020 Diabetes UK.
Similar articles
-
District health board of residence, ethnicity and socioeconomic status all impact publicly funded insulin pump uptake in New Zealand patients with type 1 diabetes.N Z Med J. 2019 Mar 8;132(1491):78-89. N Z Med J. 2019. PMID: 30845131
-
Demographic and regional disparities in insulin pump utilization in a setting of universal funding: a New Zealand nationwide study.Acta Diabetol. 2017 Jan;54(1):63-71. doi: 10.1007/s00592-016-0912-7. Epub 2016 Sep 20. Acta Diabetol. 2017. PMID: 27650535
-
Frailty of Māori, Pasifika, and Non-Māori/Non-Pasifika Older People in New Zealand: A National Population Study of Older People Referred for Home Care Services.J Gerontol A Biol Sci Med Sci. 2021 May 22;76(6):1101-1107. doi: 10.1093/gerona/glaa265. J Gerontol A Biol Sci Med Sci. 2021. PMID: 33075128
-
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.Cochrane Database Syst Rev. 2016 Jun 7;2016(6):CD005542. doi: 10.1002/14651858.CD005542.pub3. Cochrane Database Syst Rev. 2016. PMID: 27272351 Free PMC article. Review.
-
Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.Health Technol Assess. 2004 Oct;8(43):iii, 1-171. doi: 10.3310/hta8430. Health Technol Assess. 2004. PMID: 15488165 Review.
Cited by
-
Interviews with Indigenous Māori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trial.J Diabetes Metab Disord. 2023 Mar 23;22(1):861-871. doi: 10.1007/s40200-023-01215-3. eCollection 2023 Jun. J Diabetes Metab Disord. 2023. PMID: 37250371 Free PMC article.
-
Improving the Well-being of Adolescents With Type 1 Diabetes During the COVID-19 Pandemic: Qualitative Study Exploring Acceptability and Clinical Usability of a Self-compassion Chatbot.JMIR Diabetes. 2023 May 5;8:e40641. doi: 10.2196/40641. JMIR Diabetes. 2023. PMID: 36939680 Free PMC article.
-
Design of an open source ultra low cost insulin pump.HardwareX. 2022 Nov 15;12:e00375. doi: 10.1016/j.ohx.2022.e00375. eCollection 2022 Oct. HardwareX. 2022. PMID: 36425403 Free PMC article.
-
Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: A cross-sectional population study of children with type 1 diabetes in New Zealand.Lancet Reg Health West Pac. 2022 Nov 17;31:100644. doi: 10.1016/j.lanwpc.2022.100644. eCollection 2023 Feb. Lancet Reg Health West Pac. 2022. PMID: 36419466 Free PMC article.
-
Socio-Economic Inequity: Diabetes in New Zealand.Front Med (Lausanne). 2022 May 10;9:756223. doi: 10.3389/fmed.2022.756223. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35620715 Free PMC article. No abstract available.
References
REFERENCES
-
- Sherr JL, Tauschmann M, Battelino T, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies. Pediatric Diabetes. 2018;19(S27):302-325.
-
- Diabetes Control and Complications Trial Research G. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatrics. 1994;125(2):177-188.
-
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
-
- McKergow E, Parkin L, Barson DJ, Sharples KJ, Wheeler BJ. Demographic and regional disparities in insulin pump utilization in a setting of universal funding: a New Zealand nationwide study. Acta Diabetol. 2017;54(1):63-71.
-
- Wheeler BJ, Braund R, Galland B, et al. District health board of residence, ethnicity and socioeconomic status all impact publicly funded insulin pump uptake in New Zealand patients with type 1 diabetes. N Z Med J. 2019;132(1491):78.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
